Suggestions
Idioma
Guide for authors
Searcher
Journal Information
Vol. 214. Issue 7.
Pages e79-e92 Pages 357-428 (October 2014)
Cite
Cite
Share
Download PDF
More article options
Visits
4161
Vol. 214. Issue 7.
Pages e79-e92 Pages 357-428 (October 2014)
Actualización clínica

Vitamina D: presente y futuro

Vitamin D: present and future
Visits
4161
M. Varsavskya, G. Alonsob,
Corresponding author
galonso.humane@gmail.com

Autor para correspondencia.
, A. García-Martínc
a Unidad de Endocrinología, Hospital Sant Pau i Santa Tecla, Tarragona, España
b Departamento de Endocrinología. Humane Especialidades Médicas, Río Cuarto, Argentina
c Servicio de Endocrinología y Nutrición, Hospital Universitario San Cecilio, Granada, España
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Resumen

En los últimos años se ha producido un creciente interés por la vitamina D, no solo por su importante papel en el metabolismo mineral óseo, sino también por sus efectos extraóseos. La mayoría de las sociedades científicas consideran que los depósitos son suficientes si la concentración plasmática de 25-OH vitamina D está por encima de 30ng/ml y deficientes si están por debajo de 20ng/ml. La mayoría de los estudios encuentran que los suplementos de calcio más vitamina D tienen un efecto positivo en la reducción del riesgo de fractura en un 20% aproximadamente y del riesgo de caída en los ancianos, y las dosis deberían ser de 700-1.000 UI diarias. El tratamiento del déficit se puede realizar con vitamina D2, D3 o sus metabolitos activos como el calcidiol o el calcitriol. En ciertas patologías también puede utilizarse los activadores selectivos del receptor de la vitamina D.

Palabras clave:
Vitamina D
Deficiencia de vitamina D
Fracturas de estrés
Fracturas osteoporóticas
Osteoporosis
Abstract

In recent years has been a growing interest by vitamin D, not only for its important role in the bone mineral metabolism, but also by the extra-osseous effects. Most of the scientific societies consider that deposits are sufficient if the serum concentration of 25-OH vitamin D is above 30ng/ml and are considered deficient if levels are below 20ng/ml. The majority of studies found that supplements of calcium plus vitamin D have a positive effect in reducing the risk of fracture and the risk of falls in the elderly, although several specifies that doses should be 700-1.000 IU daily. The treatment of the deficit can be performed with vitamin D2, D3 as well as calcidiol or the active metabolite calcitriol. In certain pathologies also selective vitamin D receptor activators can be used.

Keywords:
Vitamin D
Vitamin D Deficiency
Fractures, Stress
Osteoporotic Fractures
Osteoporosis

Article

These are the options to access the full texts of the publication Revista Clínica Española (English Edition)
Member
Si es usted socio de FESEMI siga los siguientes pasos:

Diríjase desde aquí a la web de la >>>https://www.fesemi.org/publicaciones/revista-clinica/noticias<<< e inicie sesión mediante el formulario que se encuentra en la barra superior, pulsando sobre el candado.

Deslice el cursor hacia abajo hasta la sección "PUBLICACIONES" y pinche en "Revista Clínica Española":

>>>https://www.fesemi.org/publicaciones/revista-clinica/noticias<<<

Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to
Revista Clínica Española (English Edition)
Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
Email
Bibliografía
[1]
J.M. Sánchez Ripollés.
Breve visión histórica de la vitamina D.
Reemo., 14 (2005), pp. 20
[2]
M.F. Holick.
Sunlight and vitamin D for bone health and prevention of autoimmune disease, cancers and cardiovascular disease.
Am J Clin Nutr., 80 (2004), pp. S1678-S1688
[3]
A. Bhan, A.D. Rao, D.S. Rao.
Osteomalacia as a result of vitamin D deficiency.
Endocrinol Metab Clin N Am., 39 (2010), pp. 321-331
[4]
M. Barake, R.T. Daher, I. Salti, N.K. Cortas, L. Al-Shaar, R.H. Habib, et al.
25-hydroxyvitamin D assay variations and impact on clinical decision making.
J Clin Endocrinol Metab., 97 (2012), pp. 835-843
[5]
L. Steingrimsdottir, O. Gunnarsson, O.S. Indridason, L. Franzson, G. Sigurdsson.
Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake.
JAMA., 294 (2005), pp. 2336-2341
[6]
N. Binkley, D. Krueger.
Evaluation and correction of low vitamin D status.
Curr Osteoporos Rep., 6 (2008), pp. 95-99
[7]
B. Dawson-Hughes, R.P. Heaney, M.F. Holick, P. Lips, P.J. Meunier, R. Vieth.
Estimates of optimal vitamin D status.
Osteoporos Int., 16 (2005), pp. 713-716
[8]
A.J. Sai, R.W. Walters, X. Fang, J.C. Gallagher.
Relationship between vitamin D, parathyroid hormone, and bone health.
J Clin Endocrinol Metab., 96 (2011), pp. 436-446
[9]
H.A. Bischoff-Ferrari, E. Giovannucci, W.C. Willett, T. Dietrich, B. Dawson-Hughes.
Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes.
Am J Clin Nutr., 84 (2006), pp. 18-28
[10]
D.A. Hanley, A. Cranney, G. Jones.
Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada.
CMAJ., 182 (2010), pp. 610-618
[11]
J. González Macías, N. Guañabens Gay, C. Gómez Alonso, L. del Río Barquero, M. Muñoz Torres, M. Delgado, et al.
Guías de práctica clínica en la osteoporosis posmenopáusica, glucocorticoidea y del varón. Sociedad Española de Investigación Ósea y del Metabolismo Mineral.
Rev Clin Esp., 208 (2008), pp. 1-24
[12]
B. Dawson-Hughes, A. Mithal, J-P. Bonjour.
IOF position statement: vitamin D recommendations for older adults.
Osteoporos Int., 21 (2010), pp. 1151-1154
[13]
IOM report on calcium and vitamin D. Washington, DC: Institute of Medicine, 2010. [consultado 10 Abr 2014] Disponible en: http://www.nap.edu/catalog.php?record_id=13050
[14]
J.C. Souberbielle, J.J. Body, J.M. Lappe, M. Plebani, Y. Shoenfeld, T.J. Wang, et al.
Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice.
Autoimmun Rev., 11 (2010), pp. 709-715
[15]
M.F. Holick, N.C. Binkley, H.A. Bischoff-Ferrari, C.M. Gordon, D.A. Hanley, P. Robert, et al.
Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society Clinical Practice Guideline.
J Clin Endocrinol Metab., 96 (2011), pp. 1911-1930
[16]
M.J. Gómez de Tejada Romero, M. Sosa Henríquez, J. Del Pino Montes, E. Jódar Gimeno, J.M. Quesada Gómez, M.J. Cancelo Hidalgo, et al.
Documento de posición sobre las necesidades y niveles óptimos de vitamina D.
Rev Osteoporos Metab Miner., 3 (2011), pp. 53-64
[17]
P. Lips, N.M. van Schoor.
The effect of vitamin D on bone and osteoporosis.
Best Pract Res Clin Endocrinol Metab., 25 (2011), pp. 585-591
[18]
H.A. Bischoff-Ferrari, W.C. Willett, J.B. Wong, E. Giovannucci, T. Dietrich, B. Dawson-Hughes.
Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials.
JAMA., 293 (2005), pp. 2257-2264
[19]
S. Boonen, P. Lips, R. Bouillon, H.A. Bischoff-Ferrari, P. Vanderschueren, D. Haentjens.
Need for additional calcium to reduce the risk of hip fracture with vitamin D supplementation: evidence from a comparative meta-analysis of randomized controlled trials.
J Clin Endocrinol Metab., 92 (2007), pp. 1415-1423
[20]
I.R. Reid, M.J. Bolland, A. Grey.
Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis.
[21]
B.M. Tang, G.D. Eslick, C. Nowson, C. Smith, A. Bensoussan.
Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis.
[22]
V.A. Moyer, U.S. Preventive Services Task Force.AT Vitamin D and calcium supplementation to prevent fractures in adults: U.S. Preventive Services Task Force Recommendation Statement.
Ann Intern Med., 158 (2013), pp. 691-696
[23]
H.A. Bischoff-Ferrari, W.C. Willet, E.J. Orav, P. Lips, P.J. Meunier, R.A.A. Lyons.
Pooled analysis of vitamin D dose requirements for fracture prevention.
N Engl J Med., 367 (2012), pp. 40-49
[24]
S. Adami, S. Giannini, G. Bianchi, L. Sinigaglia, O. Di Munno, C.E. Fiore, et al.
Vitamin D status and response to treatment in post-menopausal osteoporosis.
Osteoporos Int., 20 (2009), pp. 239-244
[25]
L. Ceglia.
Vitamin D and its role in skeletal muscle.
Curr Opin Clin Nutr Metab Care., 12 (2009), pp. 628-633
[26]
C. Jackson, S. Gaugris, S.S. Sen, D. Hosking.
The effect of cholecalciferol (vitamin D3) on the risk of fall and fracture: a meta-analysis.
Q J Med., 100 (2007), pp. 185-192
[27]
H.A. Bischoff-Ferrari, B. Dawson-Hughes, H.B. Staehelin, J.E. Orav, A.E. Stuck, R. Theiler, et al.
Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials.
BMJ., 339 (2009), pp. b3692
[28]
L.D. Gillespie, M.C. Robertson, W.J. Gillespie, S.E. Lamb, S. Gates, R.G. Cumming, et al.
Interventions for preventing falls in older people living in the community.
Cochrane Database Syst Rev., 15 (2009), pp. CD007146
[29]
M.F. Holick.
Vitamin D: extraskeletal health.
Rheum Dis Clin North Am., 38 (2012), pp. 141-160
[30]
I.H. de Boer, L.F. Tinker, S. Connelly, J.D. Curb, B.V. Howard, B. Kestenbaum, for theWomen's Health Initiative Investigators, et al.
Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative.
Diabetes Care., 31 (2008), pp. 701-707
[31]
J. Wactawski-Wende, J.M. Kotchen, G.L. Anderson, A.R. Assaf, R.L. Brunner, M.J. O'Sullivan, for the Women's Health Initiative Investigators, et al.
Calcium plus vitamin D supplementation and the risk of colorectal cancer.
N Engl J Med., 354 (2006), pp. 684-696
[32]
J.M. Lappe, D. Travers-Gustafson, K.M. Davies, R.R. Recker, R.P. Heaney.
Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial.
Am J Clin Nutr., 85 (2007), pp. 1586-1591
[33]
L. Wang, J.E. Manson, Y. Song, H.D. Sesso.
Systematic review: Vitamin D and calcium supplementation in prevention of cardiovascular events.
Ann Intern Med., 152 (2010), pp. 315-323
[34]
A. Avenell, G.S. MacLennan, D.J. Jenkinson, G.C. McPherson, A.M. McDonald, P.R. Pant, RECORD Trial Group, et al.
Long-term follow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D3 and/or calcium (RECORD trial).
J Clin Endocrinol Metab., 97 (2012), pp. 614-622
[35]
L. Perna, B. Schöttker, B. Holleczek, H. Brenner.
Serum 25-hydroxyvitamin D and incidence of fatal and nonfatal cardiovascular events: a prospective study with repeated measurements.
J Clin Endocrinol Metab, 98 (2013), pp. 4908-4915
[36]
G. Bjelakovic, L.L. Gluud, D. Nikolova, K. Whitfield, J. Wetterslev, R.G. Simonetti, et al.
Vitamin D supplementation for prevention of mortality in adults.
Cochrane Database Syst Rev., 7 (2011),
[37]
H. Smith, F. Anderson, H. Raphael, P. Maslin, S. Crozier, C. Cooper.
Effect of annual intramuscular vitamin D on fracture risk in elderly men and women-a population-based, randomized, double-blind, placebo-controlled trial.
Rheumatology (Oxford)., 46 (2007), pp. 1852-1857
[38]
K.M. Sanders, A.L. Stuart, E.J. Williamson, J.A. Simpson, M.A. Kotowicz, D. Young, et al.
Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial.
JAMA., 303 (2010), pp. 1815-1822
[39]
P. Autier, S. Gandini, P. Mullie.
A systematic review: influence of vitamin D supplementation on serum 25-hydroxyvitamin D concentration.
J Clin Endocrinol Metab., 97 (2012), pp. 2606-2613
[40]
D.C. Bauer.
Calcium supplements and fracture prevention.
NEJM., 369 (2013), pp. 1537-1543
[41]
J. Wortsman, L.Y. Matsuoka, T.C. Chen, Z. Lu, M.F. Holick.
Decreased bioavailability of vitamin D in obesity.
Am J Clin Nutr., 72 (2000), pp. 690-693
[42]
J.V. Torregrosa, J. Bover, J. Cannata Andia, V. Lorenzo, A.L.M. de Francisco, I. Martinez, et al.
Recomendaciones de la Sociedad Española de Nefrología para el manejo de las alteraciones del metabolismo óseo-mineral en los pacientes con enfermedad renal crónica (SEN).
[43]
N. Garcia Dolade, G. Cereza García, M. Madurga Sanz, D. Montero Corominas.
Risk of hypercalcemia and hipervitaminosis D induced by calcifediol. Review of cases reported to the Spanish Pharmacovigilance System.
Med Clin (Barc)., 141 (2013), pp. 88-89
[44]
M. Chung, J. Lee, T. Terasawa, J. Lau, T.A. Trikalinos.
Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. Preventive Services Task Force.
Ann Intern Med., 155 (2011), pp. 827-838
[45]
C.J. Rosen, J.S. Adams, D.D. Bikle, D.M. Black, M.B. Demay, J.E. Manson, et al.
The nonskeletal effects of vitamin D: an Endocrine Society scientific statement.
Endocrine Reviews., 33 (2012), pp. 456-492
Idiomas
Revista Clínica Española (English Edition)
Article options
Tools